Switch to: References

Add citations

You must login to add citations.
  1. Epilogue: New Drugs for Neglected Diseases.Thomas Pogge & Aidan Hollis - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):329-334.
    In a widely cited 2003 article, DiMasi, Hansen, and Grabowski estimated the cost of pharmaceutical research and development to be $1.1 billion per new medicine coming onto the market in 2001. They also estimate that this cost is going up at a real rate of 7.4% annually. According to these estimates, the innovation cost per new medicine today is about $2.1 billion or $2.65 billion.
    Download  
     
    Export citation  
     
    Bookmark  
  • Access to Life-Saving Medicines and Intellectual Property Rights: An Ethical Assessment.Doris Schroeder & Peter Singer - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):279-289.
    Dying before one’s time has been a prominent theme in classic literature and poetry. Catherine Linton’s youthful death in Wuthering Heights leaves behind a bereft Heathcliff and generations of mourning readers. The author herself, Emily Brontë, died young from tuberculosis. John Keats’ Ode on Melancholy captures the transitory beauty of 19th century human lives too often ravished by early death. Keats also died of tuberculosis, aged 25. “The bloom, whose petals nipped before they blew, died on the promise of the (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Does the Pharmaceutical Sector Have a Coresponsibility for the Human Right to Health?Doris Schroeder - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):298-308.
    The highest attainable standard of health is a fundamental human right, which has been part of international law since 1948. States and their institutions are the primary duty bearers responsible for ensuring that human rights are respected, protected, and fulfilled. However, more recently it has been argued that pharmaceutical companies have a coresponsibility to fulfill the human right to health. Most prominently, this coresponsibility has been expressed in the United Nations Millennium Goal 8 Target 4. “In cooperation with pharmaceutical companies, (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations